WellWorthShares

Home
About us
Products & Services
Wellworth Insurance
Back Office
Market Analysis
Invest Options
Corp Info
- Corporate Actions
- Company Profile
Reports
- Equity
- IPO
- FO Margin

Back

Corporate News
Jubilant Pharmova appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc. As on : 02-Dec-25 09:39
Jubilant Pharmova has appointed Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc. step down subsidiary of the company.
Powered by Capital Market - Live News

SEBI Regn.No.:NSE/BSE- CM,F&O, NSE CDS: INZ000261433 | CDSL: IN-DP-CDSL-489-2020

Attention Investors: 1) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.2) For Stock Broking Transaction 'Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day...Issued in the interest of Investors.3) For Depository Transaction 'Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day...Issued in the interest of investors.4) No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.5) Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

Note:This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail.

About us

Contact Us

Careers

Privacy Policy

Score

Mobile trading activation form

Internal Control Policy

Disclaimer

Tariff Sheet

Pricing

Investor Charter -Depository Participant

POLICY

Investors Complaints

Risk Management System

Arbitration

Investor Charter -Stock Broker

Investor Awareness of Rights Entitlements

CERSAI

RMS Policy

Advisory for Investors

How To Pledge Your Shares (CDSL)

Investor Charter -Complaint

CDSL E-Voting

Freezing of trading account

Attention Investors:

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020.
2. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Useful Link:
BSE| NSE| MESI| NSDL| CDSL| SEBI| RBI| MOF| SCORE| Detail of Authorised Persons| KMP Details| Account Opening Process| Procedure for Filling of Complaint| SMART ODR

WELLWORTH PVT LTD. © Copyright 2020 All rights reserved.
Designed, Developed & content provided by CMOTS Infotech (ISO 9001:2015 certified)

Corporate News Jubilant Pharmova appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc. As on : 02-Dec-25 09:39 Jubilant Pharmova has appointed Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc. step down subsidiary of the company. Powered by Capital Market - Live News

Corporate News
Jubilant Pharmova appoints Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc. As on : 02-Dec-25 09:39
Jubilant Pharmova has appointed Daniel J. O'Connor as CEO of Jubilant Therapeutics Inc. step down subsidiary of the company.
Powered by Capital Market - Live News